Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Orchard Therapeutics plc - American Depositary Shares (NQ:ORTX)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 23, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	-
Bid (Size)	16.52 (1)
Ask (Size)	17.13 (1)
Prev. Close	16.70
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	184,260,149
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Orchard Therapeutics Announces Multiple Presentations at ASGCT 2024

May 07, 2024

Eight presentations showcase the broad applicability of HSC gene therapy to address rare neurometabolic diseases and beyond

From Orchard Therapeutics (Europe) Limited

Via GlobeNewswire

Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby Gaspar Named to Inaugural 2024 TIME100 Health List

May 03, 2024

From Orchard Therapeutics (Europe) Limited

Via GlobeNewswire

Performance

More News

Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Approved Therapy for Children with Early-onset Metachromatic Leukodystrophy

March 20, 2024

From Orchard Therapeutics (Europe) Limited

Via GlobeNewswire

Orchard Therapeutics: Q3 Earnings Insights ↗

November 13, 2023

Via Benzinga

Why Orchard Therapeutics Stock Is Soaring Today ↗

October 05, 2023

Via The Motley Fool

Orchard Therapeutics Receives FDA Approval of Lenmeldy™ (atidarsagene autotemcel), the Only Therapy for Eligible Children with Early-onset Metachromatic Leukodystrophy in the U.S.

March 18, 2024

From Orchard Therapeutics (Europe) Limited

Via GlobeNewswire

Orchard Therapeutics Announces First Patient Randomized in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome

February 05, 2024

From Orchard Therapeutics (Europe) Limited

Via GlobeNewswire

Orchard Therapeutics Announces Multiple Presentations at the 20th Annual WORLDSymposium

February 02, 2024

From Orchard Therapeutics (Europe) Limited

Via GlobeNewswire

Orchard Therapeutics Announces Agreement with the Beneluxa Consortium Enabling Reimbursed Access to Libmeldy

January 25, 2024

From Orchard Therapeutics (Europe) Limited

Via GlobeNewswire

Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases

January 24, 2024

From Orchard Therapeutics (Europe) Limited

Via GlobeNewswire

Orchard Therapeutics Receives Swissmedic Approval for Libmeldy in Early-onset MLD

December 11, 2023

From Orchard Therapeutics (Europe) Limited

Via GlobeNewswire

Orchard Therapeutics Receives U.S. FDA Fast Track Designation for OTL-203 in MPS-IH

November 30, 2023

From Orchard Therapeutics (Europe) Limited

Via GlobeNewswire

ORCHARD THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Orchard Therapeutics plc - ORTX

November 28, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Orchard Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Business Accomplishments

November 13, 2023

From Orchard Therapeutics (Europe) Limited

Via GlobeNewswire

Orchard Therapeutics Announces Presentation of Additional Positive Data from Proof-of-concept Study of OTL-203 in MPS-IH at ESGCT 2023

October 26, 2023

From Orchard Therapeutics (Europe) Limited

Via GlobeNewswire

Orchard Therapeutics Announces Multiple Presentations at ESGCT 2023

October 24, 2023

From Orchard Therapeutics (Europe) Limited

Via GlobeNewswire

Sarepta Therapeutics Stock Showing Rising Relative Strength ↗

October 09, 2023

Via Investor's Business Daily

ORCHARD THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Orchard Therapeutics plc - ORTX

October 06, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Crude Oil Down 2%; ConAgra Brands Earnings Top Views ↗

October 05, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 05, 2023

Via Benzinga

Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

October 05, 2023

Via Benzinga

Dow Tumbles Over 100 Points; Constellation Brands Raises Profit Forecast ↗

October 05, 2023

Via Benzinga

Highly Rated Biotech Orchard Therapeutics Scores A Takeover, Shares Nearly Double ↗

October 05, 2023

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023 ↗

October 05, 2023

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: SP® Plus Corporation (Nasdaq - SP), Orchard Therapeutics plc (Nasdaq - ORTX), Summit Materials (NYSE - SUM)

October 05, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Frequently Asked Questions

Is Orchard Therapeutics plc - American Depositary Shares publicly traded?

Yes, Orchard Therapeutics plc - American Depositary Shares is publicly traded.

What exchange does Orchard Therapeutics plc - American Depositary Shares trade on?

Orchard Therapeutics plc - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Orchard Therapeutics plc - American Depositary Shares?

The ticker symbol for Orchard Therapeutics plc - American Depositary Shares is ORTX on the Nasdaq Stock Market

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.